Nyrada Inc - Annual Report 2024

NYRADA INC (ASX:NYR) 20 Financial position 2024 $ 2023 $ Cash and cash equivalents 4,769,374 3,708,761 Net assets / total equity 5,051,630 4,258,438 Contributed equity 26,841,743 25,320,332 Accumulated losses (27,190,133) (27,216,732) The Directors believe the Consolidated Entity is in a strong and stable financial position to expand its current operations. Liquidity and capital resources Nyrada ended the financial year with cash of $4,769,374 and anticipates receiving an Research and Development tax incentive refund of $994,600 for FY2024 following 30 June 2024, thus further boosting capital resources. Matters subsequent to the end of the financial year No matter or circumstance has arisen since 30 June 2024 that has significantly affected, or may significantly affect the Consolidated Entity's operations, the results of those operations, or the Consolidated Entity's state of affairs in future financial years. Future developments, prospects, and business strategies Disclosure of information regarding likely developments in the operations of the Company in future financial years and the expected results of those operations is likely to result in unreasonable prejudice to the Company. Information on future developments, prospects, and business strategies have only been referred to in the Chair’s Letter and CEO Report. For further information on the Company’s business strategies and material risks, refer also to the Prospectus which is available on the Company website or ASX Announcements. Environmental regulation The Consolidated Entity is not subject to any significant environmental regulation under Australian Commonwealth or State law. Directors’ shareholdings In this section, reference is made to Share ownership. The instruments registered for trade on the Australian Securities Exchange are CHESS Depositary Interests (CDIs). One CDI is equivalent to one Share, being Class A Common Stock. The following table sets out each director’s relevant interest in shares, debentures, and rights or options in shares or Directors of the Company or a related body corporate as at the date of this report: Share Number Options Number Performance Shares John Moore 1,691,756 2,400,000 - Rüdiger Weseloh 366,666 1,200,000 - Marcus Frampton 1,178,408 1,200,000 - Christopher Cox 1,425,000 1,200,000 - Ian Dixon 10,380,699 1,800,000 5,999,400 Gisela Mautner - 1,800,000 -

RkJQdWJsaXNoZXIy MjE2NDg3